Get the latest Science News and Discoveries

Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a pioneering AI approach - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Insilico Medicine

Insilico Medicine

Photo of Nature Medicine

Nature Medicine

Photo of IPF

IPF

Related news:

News photo

Individual- and area-level incarceration and mortality - EurekAlert!

News photo

Multifaceted function of B cells in tumorigenesis - EurekAlert!

News photo

Underwater robots take to the deep to map unexplored oceans - EurekAlert!